Friday, April 28, 2017
Are Vitamin D Supplements Effective in Preventing Disease?
The trend to test for and treat alleged vitamin D deficiencies took off in 2011 with the publication of a book entitled The Vitamin D Solution - A 3-Step Strategy to Cure Our Most Common Health Problems. The suggestion by the book's author that vitamin D levels of 21-29 ng/ml are insufficient for good health were a bit of a shocker, since blood levels of vitamin D of greater than 20 ng/ml are considered normal. The book and several studies that seemed to support its thesis led to an increase in vitamin D screening blood tests, and to recommendations by many physicians that their patients consider taking vitamin D supplements.
However, the Institute of Medicine says that there is no evidence that people who have vitamin D levels above 20 ng/ml (i.e. normal vitamin D levels) will benefit from taking additional vitamin D. In addition, two studies published this year show that vitamin D supplements don't prevent heart attacks and don't protect women against cancer. An ambitious 5-year study is now underway to try to determine once and for all whether vitamin D supplements are of any use in preventing cancer, heart disease, and stroke.
I don't know about you, but I'm taking vitamin D deficiency off my list of things to worry about, at least for now.
Tuesday, April 25, 2017
'Subclinical' Hypothyroidism is Being Over-treated
Subclinical hypothyroidism is generally defined as a slightly elevated TSH (thyroid-stimulating hormone; indicating perhaps an under-responsive thyroid gland), accompanied by a number of vague and highly subjective symptoms such as tiredness, lack of motivation, and muscle aches and pains. It's called 'subclinical' hypothyroidism because levels of the two thyroid hormones, T3 and T4, are still normal, as opposed to true hypothyroidism in which there is a clear deficiency in these two hormones.
The problem is that many of the physical symptoms of hypothyroidism, such as tiredness and muscle aches and pains, are common complaints in older people. So if their TSH levels are just a little over the normal level (which also often happens with age), physicians are increasingly putting their older patients on levothyroxine, regardless of what their T3 and T4 levels are. As a result, fully 15% of older Americans are taking levothyroxine to treat their alleged symptoms.
However, recent evidence shows that other than lowering TSH levels to normal, levothyroxine doesn't have any effect on the actual "symptoms" patients are complaining about - no effect at all. If this new evidence is correct, physicians could stop prescribing levothyroxine to treat 'subclinical' hypothyroidism entirely. The proper use of levothyroxine is to treat patients with true hypothyroidism, in which T3 and T4 are demonstrably low.
Saturday, August 27, 2016
Sex Reassignment and Olympic Competition
With these three guiding principles in mind, the IOC has set forth the guidelines for persons who transition from male to female. A transgender woman who wants to compete in the Olympics must have identified herself as a woman for at least the past four years. After that, she need only prove that her testosterone levels have been below 10 nmol/l for 12 months before her first competition and remain at those levels throughout her period of eligibility. Testing to verify these levels may be required. A testosterone level of 10 nmol/l is below the level found in normal males. (Presumably there would be no athletic advantage for a transgender person who had transitioned from female to male, so such persons may compete as males without restriction.)
Some might argue that having undergone development as a male until after puberty might confer a competitive advantage and thus be unfair to other female athletes. But barring male-to-female transgender athletes from the Olympics altogether would violate both the first and second principles; that gender identity is personal and that there be a way for all athletes to compete. Unless the new rules unleash a flood of male athletes transgendering to female just to compete in the Olympics (and no one expects that), the IOC has done the right thing. Good for them!
Saturday, June 13, 2015
Still No Known Benefits From Eating Placenta
Flash forward to the present day. A recent search of the scientific literature on the subject found 49 papers, only 10 of which were deemed of sufficient quality to be included in the final analysis. None of the 10 papers offered conclusive evidence of a health benefit of eating the placenta. The bottom line is that eight years on, there is still no good evidence that eating the placenta after birth has any health benefits at all.
According to the study's authors, the health benefits and risks of eating the placenta "require further investigation." But at this point I'm wondering, why bother - why not just refrain from eating placenta in the first place? Problem solved.
Monday, May 11, 2015
Type 2 Diabetes and Sweetened Drinks
A new British study offers a tantalizing clue, although it's a bit of a "soft" study because it relies only on self-reports of dietary consumption. The study asked over 25,000 British adults about their consumption of sweetened and unsweetened drinks of all kinds, and then tracked their development of type 2 diabetes over 11 years. After adjusting for obesity, and the results showed that reducing consumption of sweetened drinks to less than 2% of total caloric intake could reduce the incidence of diabetes by 15%.
That's fine, but I certainly wouldn't know what 2% of my total caloric intake per day is, in terms of number of sweetened drinks. So how about this? Substituting just one serving/day of water or unsweetened tea/coffee for a sweetened drink was associated with a 14-25% reduction in the incidence of diabetes. Just one serving.
It's something to think about.
Thursday, February 5, 2015
"Low T" Versus Hypogonadism
Testosterone replacement therapy is only approved by the Food and Drug Administration (FDA) for the treatment of hypogonadotropism, a clinical condition characterized by measurements of blood levels of testosterone of less than 300 ng/dl and one or more clinical symptoms of androgen deficiency. Hypogonadism is not that common in young men; a study in the Journal of Clinical Endocrinology and Metabolism found that only about 5.6% of men under 70 had hypogonadism.
And yet, sales of prescription testosterone-containing gels, creams, and liquids that are absorbed through the skin totaled more than $2 billion in 2012 alone, according to an article in the New York Times. The companies who make these types of products claim with a perfectly straight face that their advertising campaigns are only aimed at educating men who may be at risk of having hypogonadism, so that they can talk to their doctor. They say that they don't condone the use of testosterone products for purposes other than those approved by the FDA, but whom are they kidding? There aren't enough men with hypogonadism in the world to support those kinds of sales numbers.
Don't buy the hype. If you're a normal young man you don't need more testosterone unless you have been properly examined and tested by a physician. Enough is plenty. And these products do have some unwanted side effects you should know about. Do your homework.
Friday, August 1, 2014
Synthetic Human Growth Hormone Use by Teens
Whether HGH actually does enhance teens’ appearance or athletic performance is still an open question. WebMD calls the effects of HGH on athletic performance “unknown”. Nor is it known whether there are any long-term negative effects of HGH use on health. And finally, there are no guarantees that HGH products sold illegally over the Internet actually contain HGH, as advertised.
The U.S. Food and Drug Administration (FDA), the agency responsible for regulating medical drugs, has approved HGH for use by prescription only, for specific medical conditions. It does not have the resources to prevent Internet sales of HGH, any more than the police are able to stop illicit prescription drug or marijuana use. Teens are taking a risk by buying HCG over the internet, without a prescription.
For more on this subject, go to a previous blog post titled "Athlete Caught Doping with Growth Hormone."
Sunday, July 27, 2014
A New Drug for Type 2 Diabetics
Now there’s a new drug that works in an entirely different way. Invokana was developed based on a basic knowledge of how the kidneys handle blood sugar. Normally, all of the sugar that is filtered in the kidneys is reabsorbed back into the bloodstream; none is excreted in the urine. It’s nature’s way of conserving energy (sugar). The mechanism of sugar reabsorption involves sugar transport “pumps” (comprised of certain proteins) in cells of the renal tubules. Invokana blocks those sugar transport pumps, so some of the some of the filtered sugar is not reabsorbed. Instead, it is excreted from the body in the urine. In diabetics (whose blood sugar is too high), that's a good thing, because it lowers the blood sugar level.
One of the potential side effects of Invokana is a slight loss of weight. That makes sense when you think about it; sugar lost in the urine equals calories lost. In diabetics who are also overweight, that could be a good thing. But I see a real danger here; what if people are led believe that Invokana would work as a diet pill (“just pee those extra calories out!”) and a black market develops for it?
I hope that doesn’t happen. There’s no data yet to prove that Invokana would result in enough weight loss to make a dieter happy. More importantly, in a person with a normal blood sugar level to begin with, Invokana might lower blood sugar to dangerously low levels. Unfortunately, people are willing to believe some pretty crazy things when marketers (black-marketers or otherwise) give them just a grain of truth.
Sunday, July 6, 2014
Inhalable Insulin, Round Three
It’ll be interesting to see whether anyone cares any more this time than they did last time. Inhalable insulin products have been attempted twice before, and both times the products were spectacular failures. Pfizer was the first pharmaceutical company to bring an inhalable insulin product (called Exubera) to market, back in 2006. The company quit making Exubera after just a year due to poor sales. Shortly thereafter, Eli Lilly halted the development of its own inhalable insulin product before it even came to market (see "Inhaled Insulin - Who Cares?").
But even in the face of these spectacular failures, it’s been hard for pharmaceutical companies to give up on the idea. The market for diabetes treatment products is huge – there are nearly 30 million diabetics in the U.S. alone. Even a small part of the sales of diabetic products would be a huge boost to the bottom line of most pharmaceutical companies. MannKind, the small company that spent nearly $2 billion developing Afreeza over the last decade, thinks that Afreeza will prove to be successful where others failed. But don’t hold your breath. Pfizer’s experience was that diabetics really didn’t mind their syringes and small needles all that much. Whether an inhalable insulin product ever gains widespread market acceptance may boil down to price.
Wednesday, June 26, 2013
The Testosterone Replacement Therapy Craze
The number of men over 40 with prescriptions for testosterone has tripled since 2001, according to a report in JAMA Internal Medicine. And that raises concerns. Do all these men actually have “low T”, with symptoms of mood swings, hot flashes, fatigue, sexual dysfunction, and a reduced muscle mass/increased fat mass?
Testosterone deficiency is due to a medical condition called hypogonadism. The Endocrine Society recommends testosterone replacement therapy to treat hypogonadism, but a blood test for testosterone is required for accurate diagnosis. According to the JAMA report, more than 25% of the men who were prescribed testosterone never even had a blood test. And of those who were tested, it is not clear how many were actually “low T”.
This may be another classic situation where intense advertising has lead to increased demand, regardless of actual need. Men who think they need testosterone for their perceived symptoms should have a blood test first, and they should be prescribed testosterone only if their testosterone is below normal limits for their age. Testosterone levels decline naturally with age, by the way. Testosterone therapy was never intended to improve sexual prowess or make a 50-year-old feel like a 20-year-old again, despite what the advertisements imply.
Wednesday, September 26, 2012
BPA and Childhood Obesity
In science, words matter. The headlines of most popular press news coverage of the JAMA article correctly used phrases like “an association” or “a link” to describe the relationship between obesity and BPA. Others were not so careful; the headline in the International Business Times was “BPA Causes Obesity in Children, New Study Shows”.
Unfortunately, such sloppy (or agenda-driven) reporting of science news only scares and confuses consumers. The American Chemistry Society, admittedly a group that itself might have an agenda, felt obligated to issue a press release on BPA this week, pointing out that the study’s authors themselves stated “…causation cannot be inferred from a cross-sectional association…”.
I’m not trying to defend BPA; frankly I think the jury is still out concerning its risk to human health. In the face of uncertainty, though, there’s nothing wrong with deciding to err on the side of caution and cutting down on the use of BPA in food containers, especially if suitable substitutes can be found. For example, BPA has already been removed from babies’ bottles. But the American Chemisty Society is right; the evidence presented in the most recent study does not prove that BPA causes or even contributes to childhood obesity. This time, the International Business Times just plain got it wrong.
Thursday, August 16, 2012
Semenya Takes the Silver Medal
Ms. Semenya, as you may recall, was the young woman whose gender was questioned after winning the 800-meter event at the world championships in 2009. After her win she was hustled out of the stadium before she could even finish her victory lap. She was out of competition for nearly a year while the International Association of Athletics Federations (IAAF), international track and field’s governing body, “decided” whether she could compete as a woman. Ultimately the IAAF decided that she could compete, but the incident caused enormous embarrassment to the 18-year-old Semenya; embarrassment that could have been avoided if the IAAF had had a gender decision policy in place and made its gender determination before the event, not after.
Following her second-place finish at the Olympic Games, there have been rumors that Ms. Semenya might have deliberately held back, taking second place to avoid re-igniting a controversy had she won the gold. Really? If you had survived an embarrassment like Ms. Semenya’s and then trained hard for two years for the Olympic Games, would you be able to deliberately not go for the gold? Somehow I doubt it.
Ms. Semenya’s gender didn’t become an issue at these past Olympic Games. The Olympic Committee planned to rely on a test of testosterone levels, but said they would only test female athletes if the athlete’s performance was questioned. Neither the IAAF nor the Olympic Committee has a policy of screening all female athletes equally beforehand, in order to avoid publicly embarrassing athletes who ultimately are not allowed to compete as women.
Saturday, July 28, 2012
HCG Diet Products Are Still Available
The Food and Drug Administration (FDA) takes a firm stand against HCG diet products, calling them unapproved, illegal and potentially dangerous. The agency has even sent warning letters to manufacturers and distributors of HCG products, warning them that they are selling illegal homeopathic drugs.
Nevertheless, on an interstate highway near where I live there’s a billboard promoting a local clinic that provides these products for weight loss! Technically, it’s legal. HCG is approved for at least one medical condition (female infertility), so physicians can order it and prescribe it. The drug laws in the U.S. allow a doctor to decide what is best for his/her patient regardless of whether or not a drug is actually approved for a particular use. So the FDA can’t stop the clinics from using HCG products as diet drugs; it can only try to strong-arm manufacturers and distributors.
The bottom line is that HCG is widely available for dieters, even though it is not approved for dieting for the FDA. Google “HCG diet” and you’ll find clinics willing to sell this snake oil, right along with news and medical sites saying it doesn’t work.
Tuesday, July 24, 2012
Bisphenol-A Banned From Plastic Babies’ Bottles
Well, good for them. But in fact the FDA took action only after the agency was asked to do so by the American Chemistry Council, a chemical industry trade group. It turns out that plastics manufacturers had already voluntarily removed BPA from babies’s bottles and sippy cups. The American Chemistry Council had asked the FDA to ban BPA from these products largely to improve the public image of the industry and these products.
The FDA has argued for some time now that that the currently available scientific evidence does not support the conclusion that the amounts of BPA ingested by adults are unsafe. Nevertheless, the agency continues to review the evidence regarding to the safety of BPA in food packaging, and is likely to take action if and when it is warranted.
Monday, April 9, 2012
FDA Not Ready to Ban BPA
BPA is used as a softening agent in hard plastics such as reusable water bottles and baby bottles, and in the plastic lining of food cans. It belongs to a class of chemicals called “endocrine disruptors” that mimic the effects of the hormone estrogen. In animal studies, toxic doses of BPA may disrupt growth and development or cause endocrine or nervous system disorders. No one knows for sure if it’s harmful at the much lower doses to which humans are exposed, but many consumers continue to be concerned.
The FDA continues to study the health effects of BPA. The agency is likely to act quickly if evidence of harm ever emerges. In the meantime, for people who remain concerned the agency offers advice on how to limit one’s exposure to the chemical.
Companies that make consumer products, on the other hand, don’t feel obligated to wait for scientifically defensible evidence – the court of public opinion is enough for them. Baby-bottle makers and some canned food companies are already searching for alternatives and phasing out their use of the chemical wherever possible.
Tuesday, February 21, 2012
Bisphenol A (BPA) in Canned Soup
In a simple but elegant experiment, researchers at Harvard University demonstrated recently that a potential endocrine disruptor called Bisphenol A (BPA) is present in significant amounts in canned foods (or at least in one brand of canned soup). The researchers employed a randomized, single-blinded, 2x2 crossover design. From a group of volunteers they randomly assigned half of the members to consume 12 ounces of canned Progresso brand vegetarian soup each day for five days. The other half of the group consumed freshly made vegetarian soup for the same five days. Subjects were free to eat whatever else they wished. At the end of the five days they measured urinary BPA levels. Then after a two-day washout period they reversed the soup diets of the members of the group, again measuring BPA levels after five days. Thus the study design gave them paired data, “canned soup” versus “fresh soup”, for each member of the group.
The results surprised even the researchers. After just five days of consuming the canned soup, the urinary concentrations of BPA were over 10 times higher than when the same individuals consumed fresh soup.
BPA is used in the manufacture of polycarbonate plastics. It is found in hard plastic water bottles and in the epoxy resin used to coat the inside of food cans to prevent the cans from corroding. BPA is detectable of in the urine of 92% of all people over six years of age, according to the 2009-2010 National Health and Nutrition Examination Survey. It’s not uncommon to find BPA in humans, in other words.
We don’t know yet whether BPA is safe at the levels being found in humans, and perhaps more importantly, what its effects might be in children. So what should we do - ban it from food and beverage containers now, or wait and see?
REFERENCE: Carwile, J.L et al. Canned Soup Consumption and Urinary Bisphenol A: A Randomized Crossover Trial. JAMA 306:2218-2220, Nov. 23/30, 2011.
(Sorry; this paper is not available free online. Check your school’s library.)
Saturday, March 12, 2011
The Simeons Therapy Diet Fad
Frankly, the New York Times article stirs up an old “controversy” that shouldn’t still exist. Anyone who can stick to a 500 calorie-per-day diet will lose weight. Weight loss accomplished on the Simeons therapy diet has nothing to do with the added hCG, according to a well-documented review written in 1995.
The FDA has warned that non-injectable “homeopathic” forms of hCG available over the counter cannot be labelled as having have weight-loss properties. But there’s a long-standing tradition of allowing physicians to decide what is best for each patient (in consultation with the patient, of course). Therefore, physicians can legally prescribe injectable hCG as part of a diet plan if they wish, whether or not it works. And of course, they are free to charge whatever they like for the consultation/evaluation prior to writing the prescription.
Acquaint yourself with the facts, and then don’t waste your money on this diet.
Monday, October 18, 2010
Canada Declares BPA Plastic to be Toxic
BPA falls into a category of substances known as endocrine disruptors. As a group, endocrine disruptors either mimic or block the action of hormones, thereby disrupting the body’s functions. In laboratory animals, high concentrations of BPA have been shown to mimic the female hormone estrogen. Several studies reported by The Endocrine Society, a well-known scientific group, suggest that endocrine disruptors such as BPA may have adverse health affects that include infertility and cancer.
Canada and about half a dozen states in the U.S. have already banned the use of BPA in children’s products. Canada’s recent action paves the way for future bans on the use of BPA in food and beverage containers for adults as well, and for increased control over manufacturing processes involving BPA.
So far the U.S. government has taken no action, saying there is not enough evidence that the substance harms humans. But research is underway, and time will tell.
Wednesday, July 7, 2010
It's Official: She Can Compete
Caster Semenya May Compete. “The process initiated in 2009 in the case of Caster Semenya (RSA) has been completed. The IAFF accepts the panel of medical experts that she can compete with immediate effect. Please note that the medical details of the case remain confidential and the IAAF will make no further comment on the matter.” (IAFF statement)
Remember the old “Where’s the beef?” commercials for Wendy’s chain of restaurants? One might ask, “Where’s the proof?” Out of fairness to all athletes in sports, sports governing bodies should develop understandable policies, guidelines, or criteria for gender assignment in sports. But it won’t be easy (gender IS ambiguous, sometimes), so I’m betting the IAAF won’t even attempt it.
The Wendy’s commercial ended with the remark, “(I don’t think there’s anybody back there…)” IAAF, are you listening?
Friday, April 16, 2010
Inflammation and Type 2 Diabetes
Scientists caution that no one should start taking salsalate just yet to try to prevent or treat diabetes or atherosclerosis. Larger clinical studies involving many more patients will be needed before salsalate is becomes a standard treatment for these diseases. Nevertheless, these preliminary findings bring us just a little bit closer to an understanding of the link between obesity and inflammation, and whether (and if so, how) inflammation contributes to chronic diseases such as Type 2 diabetes.